Gastrointestinal Endoscopy Global Market Report 2024

The gastrointestinal endoscopy market size has grown strongly in recent years. It will grow from $14.65 billion in 2023 to $15.72 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The expansion during the historical period can be attributed to the increasing prevalence of gastrointestinal disorders, a heightened awareness about early disease detection, the growing aging population, reimbursement policies, and the expanding applications in therapeutic procedures.

The gastrointestinal endoscopy market size is expected to see strong growth in the next few years. It will grow to $20.22 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The anticipated growth in the forecast period can be attributed to the rising demand for minimally invasive procedures, increasing investment in healthcare infrastructure, the growth of the geriatric population, expanding applications in oncology diagnosis, and the rising adoption of capsule endoscopy. Key trends expected in the forecast period include the increasing use of artificial intelligence in endoscopy, the development of disposable endoscopes, a rising demand for flexible endoscopes, a focus on tele-endoscopy services, and the integration of robotics in gastrointestinal endoscopy.

The growth of the gastrointestinal endoscopy market is being propelled by the increasing prevalence of gastrointestinal diseases. Gastrointestinal diseases, affecting the organs involved in digestion and food processing, prompt the need for effective diagnostic and therapeutic interventions. Gastrointestinal endoscopy, a widely utilized technique, enables the identification of abnormalities, facilitates biopsy tissue sampling, and supports therapeutic procedures in the diagnosis and treatment of these diseases. For instance, Cancer Research UK predicts a 5% increase in the incidence rate of pancreatic cancer in the UK from 2023 to 2025. Additionally, a research article published in the Journal of the Canadian Association of Gastroenterology in March 2023 forecasts an increase in the incidence rate of inflammatory bowel disease in Canada from 825 per 100,000 in 2023 to 1075 per 100,000 in 2035. The rising prevalence of gastrointestinal diseases is a significant driver of the gastrointestinal endoscopy market.

The gastrointestinal endoscopy market is experiencing growth due to the aging population. The demographic shift towards an aging population, characterized by a higher proportion of individuals aged 65 and older, is contributing to increased demand for health screenings, including gastrointestinal screenings. Older adults are more likely to undergo gastrointestinal endoscopy procedures, such as colonoscopies, for the early detection of colorectal cancer and other gastrointestinal issues. According to the World Health Organization, by 2030, one out of every six individuals globally will be 60 years old or older. The global population of individuals aged 60 and older is expected to reach 1.4 billion in 2025 and double to 2.1 billion by 2050. The growing aging population is a key factor driving the gastrointestinal endoscopy market.

Innovation in gastrointestinal endoscopic devices is a prominent trend in the gastrointestinal endoscopy market, with major companies introducing advanced devices to maintain their market positions. For example, Fujifilm Healthcare Americas Corporation launched TRACMOTION in December 2021, featuring a 360° rotatable jaw for endoscopic submucosal dissection (ESD). This innovation facilitates easy grasping and re-grasping of large lesions in the gastrointestinal tract, reducing procedure times and enhancing visualization for clinicians.

Major companies in the gastrointestinal endoscopy market are focused on developing advanced gastrointestinal diagnosis technologies to enhance their market presence. These technologies, utilizing artificial intelligence (AI) for earlier disease detection and more accurate diagnostics, contribute to improved treatment planning and patient outcomes. Fujifilm's CAD EYE function for Upper Gastrointestinal diagnosis, launched in March 2023, utilizes AI technology to aid in the early detection and characterization of abnormalities in the stomach and esophagus, providing clinicians with valuable visualization modes and tools for efficient lesion navigation.

In April 2023, Boston Scientific acquired Apollo Endosurgery for $615 million, aiming to enhance its product offerings in endoluminal surgery procedures and endo-bariatric solutions. Apollo Endosurgery, a manufacturer of endoscopy devices and solutions for gastrointestinal endoscopy, adds valuable capabilities to Boston Scientific's portfolio.

Major companies operating in the gastrointestinal endoscopy market report are Merck & Co Inc., Medtronic plc, Johnson & Johnson MedTech, FUJIFILM Holdings Corporation, Stryker Corporation, Atrium Health Co, Boston Scientific Corporation, Regeneron Pharmaceuticals Inc., Envaste Limited, Olympus Corporation, Intuitive Surgical Inc., HOYA Corporation, Smith & Nephew Plc, Steris plc, Coloplast AS, Teleflex Incorporated, Cook Group Inc., Karl Storz SE & Co. KG, Ambu A/S, Richard Wolf GmbH, SonoScape Medical Corp., EndoChoice Holdings Inc., Allied Digestive Health LLC, Endogastric Solutions Inc., Micro-Tech Endoscopy Inc., CapsoVision Inc., Medrobotics Corporation, EndoMed Systems GmbH, Motus GI Holdings Inc., Endogene Ltd.

North America was the largest region in the gastrointestinal endoscopy market in 2023. The regions covered in the gastrointestinal endoscopy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the gastrointestinal endoscopy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The primary types of gastrointestinal endoscopy products include endoscopes, camera heads, visualization systems, biopsy devices, capsule endoscopes, transmitters and receivers, and robot-assisted endoscopes. Endoscopes, as medical instruments, are designed for visualizing and examining the interior of the human body or other inaccessible areas. These products find applications in various medical scenarios, such as OGIB (obscure GI tract bleeding), Crohn’s disease, small intestine tumors, and others. They are employed in settings such as hospitals, ambulatory surgery centers or clinics, among others.

The gastrointestinal endoscopy market research report is one of a series of new reports that provides gastrointestinal endoscopy market statistics, including gastrointestinal endoscopy industry global market size, regional shares, competitors with a gastrointestinal endoscopy market share, detailed gastrointestinal endoscopy market segments, market trends and opportunities, and any further data you may need to thrive in the gastrointestinal endoscopy industry. This gastrointestinal endoscopy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gastrointestinal endoscopy market consists of revenues earned by entities by providing colonoscopy, capsule endoscopy, and flexible sigmoidoscopy. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastrointestinal endoscopy market also includes the sales of ultrasound endoscopes, balloon dilators, gastrointestinal stents, biopsy devices, retrieval devices, ERCP devices, hemostasis devices, capsule endoscopes, gastrointestinal video scopes, and visualization systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).


The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.